UBS analyst Kevin Caliendo raised the firm’s price target on McKesson (MCK) to $920 from $860 and keeps a Buy rating on the shares.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK:
- Trump Trade: Trump administration prepares new probe into pharma prices
- Trump admin prepares new probe into U.S. pharma prices, FT says
- Citius Oncology announces distribution agreement with McKesson
- McKesson’s Strategic Initiatives and Growth Potential Justify Buy Rating and Increased Price Target
- McKesson price target raised to $900 from $820 at Jefferies